Search

Search Constraints

You searched for: Author/Creator Cerrato, Aniello

Search Results

1. Analysis of CCDC6 as a novel biomarker for the clinical use of PARP1 inhibitors in malignant pleural mesothelioma. (September 2019)

3. New therapeutic perspectives in CCDC6 deficient lung cancer cells. Issue 9 (24th October 2014)

5. USP7 inhibitors, downregulating CCDC6, sensitize lung neuroendocrine cancer cells to PARP-inhibitor drugs. (May 2017)